Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06447220

Washed Microbiota Transplantation for Malnutrition

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
The Second Hospital of Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malnutrition is a pathological condition in which dietary intake fails to meet the body's energetic or nutritional needs. It may be caused by macronutrient or micronutrient deficiencies, high energy expenditure, impaired nutrient absorption or assimilation. Malnutrition can affect all stages of life. In adults, malnutrition is strongly associated with poor clinical outcomes such as increased morbidity, increased mortality and prolonged hospitalization. In children, malnutrition can lead to growth retardation, cognitive impairment and immune dysfunction.

Detailed description

The gut microbiota of malnourished patients is different from that of healthy people. The diversity of the gut microbiota of patients with severe malnutrition reduced and the abundance of Proteobacteria significantly increased, as well as pathogenic genera such as Klebsiella, Escherichia coli, Shigella, and Streptococcus. This suggests that gut microbiota plays an important role in the occurrence and development of malnutrition. Dietary intervention targeting gut microbiota can quickly improve children's malnutrition, promote weight gain and increase protein levels that promote bone growth and nerve development. Exclusive enteral nutrition combined with immediate washed microbiota transplantation(WMT) can rapidly improve the nutritional status of patients with Crohn's disease compared with those with delayed WMT. Gut microbiota has been confirmed to be closely related to malnutrition. Improving the disordered gut microbiota in malnourished patients may become a potential treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREwashed microbiota transplantationThe prepared microbiota suspension was infused into the patients' gut.

Timeline

Start date
2023-12-17
Primary completion
2030-12-01
Completion
2031-04-01
First posted
2024-06-07
Last updated
2025-07-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06447220. Inclusion in this directory is not an endorsement.